期刊文献+

地氯雷他定联合甘露聚糖肽治疗慢性特发性荨麻疹对血清白细胞介素-24的影响 被引量:1

Observation of effect of the desloratadine treating chronic idiopathic urticaria with mannatide upon the interleukin-2-4 in blood serum
下载PDF
导出
摘要 目的观察地氯雷他定联合甘露聚糖肽治疗慢性特发性荨麻疹(CIU)对血清白细胞介素(IL)-2,IL-4的影响。方法治疗组患者30例给予地氯雷他定5 mg/d口服,甘露聚糖肽口服液20 mg/d,每日2次口服;对照组患者仅给予地氯雷他定5 mg/d口服。2周1个疗程,连服2个疗程。健康组和治疗组CIU患者在治疗前、治疗后检测血清IL-2,IL-4的含量。结果治疗组CIU患者在治疗前与健康人比较其IL-2明显降低,而IL-4明显增高。治疗组治疗后,血清IL-2增高,而IL-4则降低。结论地氯雷他定联合甘露聚糖肽治疗CIU,可调节机体的免疫功能。 Objective To observe the effect of the desloratadine treating chronic idiopathic urticaria with mannatide upon the interleukin-2 and interleukin-4 in blood serum.Method Thirty patients in treated group took orally desloratadine of 5 mg/d and mannatide oral liquid of 20 mg/d two times a day separately while those in control group only desloratadine of 5 mg/d as a course of treatment during two weeks continuously in two cure periods.Interleukin-2 and interleukin-4 of their blood serums were detected before and after treatment.Results Patients in treated group were found to have an abvious reduction of the interleukin-2 and have a clear rise of interleukin-4 in comparison with the healthy person,while the treated group were found to have a rise of interleukin-2 and a reduction of interleukin-4 in their blood serums after being cured.Conclusion This method is in a position to boost up the immunologic function in organism and make a rise of interleukin-2 and a reduction of interleukin-4 in the blood serum.
出处 《实用医技杂志》 2011年第5期455-456,共2页 Journal of Practical Medical Techniques
关键词 荨麻疹 白细胞介素2 白细胞介素4 Urticaria Interleukin-2 Interleukin-4
  • 相关文献

参考文献6

二级参考文献12

  • 1吴瑞勤,孙越,朱光斗,郑捷,徐慧珍,张定国,姜培红,郑志忠,杨勤萍.依巴斯汀治疗慢性特发性荨麻疹临床观察[J].临床皮肤科杂志,2004,33(8):507-507. 被引量:53
  • 2张开明 尹国华 等.药疹患者血清可溶性白介素2受体含量测定[J].中华皮肤科杂志,1995,28:30-31.
  • 3张开明,中华皮肤科杂志,1995年,28卷,30页
  • 4Spergel JM, Mizoguchi E, Oettgen H, et al. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis[J]. J Clin Invest, 1999,103(8):1103-1111.
  • 5Salgame P,Abrams JS,Clayberger C,et al.Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones[J]. Science, 1991,254(5029):279-282.
  • 6Tang M, Kemp A, Varigos G. IL-4 and interferon-gamma production in children with atopic disease[J]. Clin Exp Immunol, 1993,92(1):120-124.
  • 7Kimura M, Tsuruta S, Yoshida T,et al. Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis[J]. J Allergy Clin Immunol, 1998,102(2):238-244.
  • 8Hurst M, Spencer CM. Ebastine: an update of its use in allergic disorders[J]. Drugs, 2000, 59(4): 981-1006.
  • 9Kaplan AP. Clinical practice. Chronic urticaria and angioedema[J]. N Engl J Med, 2002, 346(3): 175-179.
  • 10Robert J. Efficacy and tolerability omparision of ebastine 10 and 20 mg with loratadine 10 mg[J]. Clin Drug invest, 1998, 16(6):413-420.

共引文献44

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部